Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

1. Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update.Bioengineering (Basel, Switzerland) · 2023
   Review
2. Turkish journal of biology = Turk biyoloji dergisi · 2022
   Article
3. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).Bone marrow transplantation · 2020
   Article
4. Stem cell autograft and allograft in autoimmune diseases.Clinical and experimental medicine · 2016
   Review
5. Survival and migration of pre-induced adult human peripheral blood mononuclear cells in retinal degeneration slow (rds) mice three months after subretinal transplantation.Current stem cell research & therapy · 2014
   Article
6. CD4+ T cell-depleted lymphocyte infusion impairs neither the recovery of recipient thymus nor the development of transplanted thymus.Journal of immunology (Baltimore, Md. : 1950) · 2013
   Article
7. High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.Seminars in arthritis and rheumatism · 2011
   Article
8. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells.Journal of biomedical science · 2011
   Article
9. Behçet's Disease.Current treatment options in neurology · 2011
   Article
10. Combination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate.Stem cells and development · 2011
    Article
11. Mesenchymal stem cells as therapeutics.Annual review of biomedical engineering · 2010
    Review
12. Allogeneic stem cell transplantation for rheumatic autoimmune diseases.F1000 medicine reports · 2010
    Article
13. Stem cell transplantation for autoimmune diseases.Haematologica · 2010
    Article
14. Stem cell transplantation for rheumatic autoimmune diseases.Arthritis research & therapy · 2008
    Review
15. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.Annals of the rheumatic diseases · 2007
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as